Bad - Recensione dipendente - CEO-Founder presso NeoGenomics

1,0
20 feb 2024
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

It is a job that is all

Svantaggi

Big Quality Issues. due to neglect

avatar
Risposta di NeoGenomics
2y
Thanks for your review. As Quality is one of our Core Values at Neo, please reach out to your People & Culture business partner, so that we can dive further into your concerns.

Esplora altre recensioni su NeoGenomics

5,0
11 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Growing business opportunities for many job seekers

Svantaggi

Ever changing approach on direction on projects

2,0
2 mar 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

The workforce wants to do the right thing. We take pride in knowing our services impact people's lives everyday.

Svantaggi

Constant turnover, lack of communication throughout - top to bottom. Leadership is struggling and not performing, Most of their attempts to improve growth have lost money. This is factual, not to be mistaken with statements from a disgruntled employee. An article published after the recent earnings release emphasized NEO's 5-year Return on Invested Capital is -10.5%, meaning management doesn't spend our capital wisely. This, along with heavy debt, minimal cash and returns at the bottom of the healthcare sector, should make you pause and do more research before jumping on board.

5
Vedi recensioni per: Utile|Valutazione|Data|Tutto